|
Turner BioSystems Combines with Promega to
Expand Integrated Systems Offerings
Madison, WI USA.
(August 3, 2009) Promega Corporation announces the recent purchase of
Turner BioSystems Inc. to grow their mutual interest in offering high
quality integrated systems (optimized instrument with reagents) to life
scientists in research, drug discovery and clinical diagnostics. This
latest Promega expansion continues the existing synergies between the
two companies. Together they have delivered integrated bioluminescent
systems with Turner’s luminometers and world-class bioluminescent
technologies from Promega.
“This is
a natural next move for Turner,” explains Turner President Mike
Molkelke. “Over the years, innovating with Promega has created
productive instrument/reagent systems that scientists highly value. Both
companies are eager to optimize this total systems approach for the
bench top.”
“The
Turner quality and our long standing relationship makes this a great
enhancement for all of our customers,” says Promega CEO Bill Linton.
“Scientists value quality integrated systems because it frees them up to
focus on the other demands in their lab. This purchase allows us to
offer these systems for more applications.”
Turner
and Promega have worked together in offering the Glomax® Luminometer
line that is optimized for Promega bioluminescent assays. Turner offers
microplate and single tube reader luminometers, fluorometers,
photometers and multimode instruments for life science labs. Turner
will continue its operations out of Sunnyvale, CA.
Contact:
Penny Patterson
Director, Corporate Affairs
Promega Corporation
Phone: 001 (608) 274-4330
E-mail: penny.patterson@promega.com
# # # # |
